Amphetamine-Dextroamphetamine

DRUG2 trials

Sponsors

Emory University, Eva Szigethy

Conditions

Cognitive ImpairmentIdiopathic HypersomniaLong COVIDNarcolepsy Without Cataplexy

Phase 2

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

CompletedNCT03772314

Emory UniversityIdiopathic Hypersomnia, Narcolepsy Without Cataplexy

Start: 2019-04-15End: 2023-05-04Updated: 2024-05-23

Phase 4

Addressing Cognitive Fog in Long-COVID-19 Patients

TerminatedNCT05597722

Eva SzigethyCognitive Impairment, Long COVID

Start: 2023-04-04End: 2023-05-18Updated: 2024-07-22

Related Papers

Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial.

2024-09-211 citations